Skip to Main Content

Author Details

Wei Zhang
The University of Texas MD Anderson Cancer Center
1988
304
75
PMIDPaper TitleJournal TitlePublished Year
36226489Concomitant targeting of FLT3 and BTK overcomes FLT3 inhibitor resistance in acute myeloid leukemia through the inhibition of autophagy.Haematologica2023
36226489Concomitant targeting of FLT3 and BTK overcomes FLT3 inhibitor resistance in acute myeloid leukemia through the inhibition of autophagy.Haematologica2023
36841771Combining manipulation of integration loci and secretory pathway on expression of an Aspergillus niger glucose oxidase gene in Trichoderma reesei.Microb Cell Fact2023
37085610FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via ERK suppression in AML cells and CXCR4/E-selectin inhibition enhances anti-leukemia efficacy of FLT3-targeted therapy in AML.Leukemia2023
37269223Arabidopsis EIN2 represses ABA responses during germination and early seedling growth by inactivating HLS1 protein independently of the canonical ethylene pathway.Plant J2023
37078252Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells.Haematologica2023
36865133The multi-kinase inhibitor CG-806 exerts anti-cancer activity against acute myeloid leukemia by co-targeting FLT3, BTK, and Aurora kinases.Res Sq2023
36740203Transcriptome profiling and bioinformatic analysis of the effect of ganoderic acid T prevents Sendai virus infection.Gene2023
37085610FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via ERK suppression in AML cells and CXCR4/E-selectin inhibition enhances anti-leukemia efficacy of FLT3-targeted therapy in AML.Leukemia2023
37078252Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells.Haematologica2023
37269223Arabidopsis EIN2 represses ABA responses during germination and early seedling growth by inactivating HLS1 protein independently of the canonical ethylene pathway.Plant J2023
36841771Combining manipulation of integration loci and secretory pathway on expression of an Aspergillus niger glucose oxidase gene in Trichoderma reesei.Microb Cell Fact2023
36740203Transcriptome profiling and bioinformatic analysis of the effect of ganoderic acid T prevents Sendai virus infection.Gene2023
36865133The multi-kinase inhibitor CG-806 exerts anti-cancer activity against acute myeloid leukemia by co-targeting FLT3, BTK, and Aurora kinases.Res Sq2023
35114569Inhibition of BCL2A1 by STAT5 inactivation overcomes resistance to targeted therapies of FLT3-ITD/D835 mutant AML.Transl Oncol2022
35392587The Efficacy of Adjuvant Targeted Therapy in Patients with Advanced Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.Comput Math Methods Med2022
35976701Revisiting the multisite phosphorylation that produces the M-phase supershift of key mitotic regulators.Mol Biol Cell2022
36612165Construction of an Immune Escape-Related Signature in Clear Cell Renal Cell Carcinoma and Identification of the Relationship between IFNAR1 and Immune Infiltration by Multiple Immunohistochemistry.Cancers (Basel)2022
35252772Effect of the Ancillary Ligand on the Performance of Heteroleptic Cu(I) Diimine Complexes as Dyes in Dye-Sensitized Solar Cells.ACS Appl Energy Mater2022
35114569Inhibition of BCL2A1 by STAT5 inactivation overcomes resistance to targeted therapies of FLT3-ITD/D835 mutant AML.Transl Oncol2022
35392587The Efficacy of Adjuvant Targeted Therapy in Patients with Advanced Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.Comput Math Methods Med2022
36612165Construction of an Immune Escape-Related Signature in Clear Cell Renal Cell Carcinoma and Identification of the Relationship between IFNAR1 and Immune Infiltration by Multiple Immunohistochemistry.Cancers (Basel)2022
35976701Revisiting the multisite phosphorylation that produces the M-phase supershift of key mitotic regulators.Mol Biol Cell2022
35252772Effect of the Ancillary Ligand on the Performance of Heteroleptic Cu(I) Diimine Complexes as Dyes in Dye-Sensitized Solar Cells.ACS Appl Energy Mater2022
34108527DNA-PK inhibitor peposertib enhances p53-dependent cytotoxicity of DNA double-strand break inducing therapy in acute leukemia.Sci Rep2021
34108527DNA-PK inhibitor peposertib enhances p53-dependent cytotoxicity of DNA double-strand break inducing therapy in acute leukemia.Sci Rep2021
33511738Clioquinol inhibits cell growth in a SERCA2-dependent manner.J Biochem Mol Toxicol2021
34737807CircRNA expression profiling of PBMCs from patients with hepatocellular carcinoma by RNA-sequencing.Exp Ther Med2021
33511738Clioquinol inhibits cell growth in a SERCA2-dependent manner.J Biochem Mol Toxicol2021
34737807CircRNA expression profiling of PBMCs from patients with hepatocellular carcinoma by RNA-sequencing.Exp Ther Med2021
32493919Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression.Nat Commun2020
32493919Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression.Nat Commun2020
33316771Prognostic and predictive roles of DNA mismatch repair status in colon cancer patients treated with oxaliplatin-based chemotherapy: a retrospective study.J Physiol Pharmacol2020
32984009First Report of Sorafenib in Patients With Acute Myeloid Leukemia Harboring Non-Canonical <i>FLT3</i> Mutations.Front Oncol2020
33069695Role of RIN1 on telomerase activity driven by EGF-Ras mediated signaling in breast cancer.Exp Cell Res2020
33016929Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors.J Clin Invest2020
33316771Prognostic and predictive roles of DNA mismatch repair status in colon cancer patients treated with oxaliplatin-based chemotherapy: a retrospective study.J Physiol Pharmacol2020
33069695Role of RIN1 on telomerase activity driven by EGF-Ras mediated signaling in breast cancer.Exp Cell Res2020
33016929Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors.J Clin Invest2020
32984009First Report of Sorafenib in Patients With Acute Myeloid Leukemia Harboring Non-Canonical <i>FLT3</i> Mutations.Front Oncol2020
30315273Targeted next-generation sequencing of endometrial cancer and matched circulating tumor DNA: identification of plasma-based, tumor-associated mutations in early stage patients.Mod Pathol2019
31687203One-Year Outcomes of 1 Dose versus 3 Loading Doses Followed by Pro Re Nata Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration: The ARTIS Trial.J Ophthalmol2019
30315273Targeted next-generation sequencing of endometrial cancer and matched circulating tumor DNA: identification of plasma-based, tumor-associated mutations in early stage patients.Mod Pathol2019
31350294Chromosomal Instability in Tumor Initiation and Development.Cancer Res2019
31687203One-Year Outcomes of 1 Dose versus 3 Loading Doses Followed by Pro Re Nata Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration: The ARTIS Trial.J Ophthalmol2019
31350294Chromosomal Instability in Tumor Initiation and Development.Cancer Res2019
29138344Targeting the MYCN-PARP-DNA Damage Response Pathway in Neuroendocrine Prostate Cancer.Clin Cancer Res2018
30266942Systems biology approach reveals a link between mTORC1 and G2/M DNA damage checkpoint recovery.Nat Commun2018
29138344Targeting the MYCN-PARP-DNA Damage Response Pathway in Neuroendocrine Prostate Cancer.Clin Cancer Res2018
29643063Evaluation of Prexasertib, a Checkpoint Kinase 1 Inhibitor, in a Phase Ib Study of Patients with Squamous Cell Carcinoma.Clin Cancer Res2018
  • 1 - 50 of 608

Recommended Authors

Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 0
Young K Song
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 6
Bin Yan
The University of Hong Kong
Career Start Year 2003
Number of shared co-authors 3
Yuelin J Zhu
National Cancer Institute, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 1
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 6
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 1
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 1
Krishna P Bhat
Department of Neurosurgery at the University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 29
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 2
Yaoqi Alan Wang
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 24
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 27
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 17
Qing-Rong Chen
Center for Biomedical Informatics and Information Technology
Career Start Year 1996
Number of shared co-authors 4
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 27
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 5
Phillip Buckhaults
University of South Carolina
Career Start Year 1993
Number of shared co-authors 1
Qimin Zhan
Peking University Cancer Hospital
Career Start Year 1989
Number of shared co-authors 2
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 30
Enzo Medico
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year 1988
Number of shared co-authors 4
Patrick Kwok-Shing Ng
The University of Texas MD Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 31
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 27
Mark A Watson
Washington University School of Medicine
Career Start Year 1987
Number of shared co-authors 34
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 13
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 0
Olli Kallioniemi
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 4
David D L Bowtell
Peter MacCallum Cancer Centre
Career Start Year 1983
Number of shared co-authors 20
Ching C Lau
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 39
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 10
Francisca Vazquez
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 13
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1970
Number of shared co-authors 26

Collaborators

Gregory N Fuller
MD Anderson Cancer Center
Co-authored papers 42
David Cogdell
The University of Texas MD Anderson Cancer Center
Co-authored papers 35
Limei Hu
Aier Eye Hospital of Wuhan University
Co-authored papers 29
Ilya Shmulevich
Institute for Systems Biology
Co-authored papers 25
Anil K Sood
The University of Texas MD Anderson Cancer Center
Co-authored papers 22
Da Yang
Co-authored papers 16
Yuexin Liu
The University of Texas MD Anderson Cancer Center
Co-authored papers 16
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Co-authored papers 16
Jonathan C Trent
Sylvester Comprehensive Cancer Center, University of Miami
Co-authored papers 15
Kelly K Hunt
The University of Texas MD Anderson Cancer Center
Co-authored papers 12
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 12
Raymond Sawaya
The University of Texas M.D. Anderson Cancer Center, American University of Beirut
Co-authored papers 12
Wai-Kwan Alfred Yung
University of Texas M.D. Anderson Cancer Center
Co-authored papers 11
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 10
Raphael E Pollock
James Cancer Center, The Ohio State University
Co-authored papers 9
Rajesha Rupaimoole
Harvard Medical School, Beth Israel Deaconess Medical Center
Co-authored papers 8
Kevin R Coombes
Medical College of Georgia
Co-authored papers 8
Adel K El-Naggar
MD Anderson Cancer Center
Co-authored papers 7
Kenneth Aldape
National Cancer Institute
Co-authored papers 6
Mien-Chie Hung
Co-authored papers 6
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Ioan Tabus
Tampere University of Technology
Co-authored papers 6
Steven M Kornblau
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Yingmei Wang
Tianjin Medical University General Hospital
Co-authored papers 6
Chad V Pecot
University of North Carolina at Chapel Hill
Co-authored papers 6
Jorge Cortes
Georgia Cancer Center
Co-authored papers 6
Nora M Navone
MD Anderson Cancer Center
Co-authored papers 5
Frederick F Lang
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 5
Gautam Borthakur
MD Anderson Cancer Center
Co-authored papers 5
Release 1.2